MyMSTeam

That's a really important question. Ampyra (dalfampridine) is specifically FDA-approved to help improve walking in adults with MS. If someone is not currently walking, the medication's intended purpose may not apply in the same way. That said, this is absolutely a conversation to have with a neurologist, as every person's Show Full Answer

That's a really important question. Ampyra (dalfampridine) is specifically FDA-approved to help improve walking in adults with MS. If someone is not currently walking, the medication's intended purpose may not apply in the same way. That said, this is absolutely a conversation to have with a neurologist, as every person's MS journey is different. A doctor can weigh the potential benefits against the risks, which include:

- Seizure risk, especially in people with kidney problems
- Side effects like dizziness, headache, nausea, and insomnia
- Kidney function needs to be monitored regularly while on Ampyra

A neurologist is the best person to determine whether Ampyra makes sense given someone's current mobility level and overall health picture.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Treatments

Ampyra